Abstract: Neurons in the embryonic and peripheral nervous system respond to injury by activating transcriptional programs supportive of axon growth, ultimately resulting in functional recovery. In contrast, neurons in the adult central nervous system (CNS) possess a limited capacity to regenerate axons after injury, fundamentally constraining repair. Activating pro-regenerative gene expression in CNS neurons is a promising therapeutic approach, but progress is hampered by incomplete knowledge of the relevant transcription factors. An emerging hypothesis is that factors implicated in cellular growth and motility outside the nervous system may also control axon growth in neurons. We therefore tested sixty-nine transcription factors, previously identified as possessing tumor suppressive or oncogenic properties in nonneuronal cells, in assays of neurite outgrowth. This screen identified YAP1 and E2F1 as enhancers of neurite outgrowth, and PITX1, RBM14, ZBTB16, and HHEX as inhibitors. Follow-up experiments are focused on the tumor suppressor HHEX, one of the strongest growth inhibitors. HHEX is widely expressed in adult CNS neurons, including corticospinal tract neurons after spinal injury, but is present only in trace amounts in immature cortical neurons and adult peripheral neurons. HHEX overexpression in early postnatal cortical neurons reduced both initial axonogenesis and the rate of axon elongation, and domain deletion analysis strongly implicated transcriptional repression as the underlying mechanism. These findings suggest a role for HHEX in restricting axon growth in the developing CNS, and substantiate the NOT THE PUBLISHED VERSION; this is the author's final, peer-reviewed manuscript. The published version may be accessed by following the link in the citation at the bottom of the page.
Introduction
In contrast to the peripheral nervous system (PNS) and the developing central nervous system (CNS), axons in the mature CNS generally fail to regenerate after injury. While external inhibitory factors contribute (Case and Tessier-Lavigne, 2005; Yiu and He, 2006) , a major reason for regenerative failure is a loss of growth ability that is intrinsic to CNS neurons (Goldberg et al., 2002 , Blackmore and Letourneau, 2006 and Sun and He, 2010 . Intervening in the CNS cell body response, either by increasing pro-regenerative gene expression or eliminating growth-inhibitory gene expression, has emerged as a promising strategy to promote axon growth (Park et al., 2008 , Moore et al., 2009 , Liu et al., 2010b and Blackmore et al., 2012 . Given the substantial amount and diversity of cellular material needed for axon growth, it is probable that multiple targets must be altered for optimal regeneration (Sun et al., 2011) . Thus transcription factors (TFs), which coordinate the expression of multiple genes, are well suited to have a profound effect on axonal growth (Moore and Goldberg, 2011 and Patodia and Raivich, 2012) . A number of TFs have been identified that regulate axon regeneration, but our understanding remains incomplete and additional transcriptional regulators of axon growth almost certainly await discovery (Moore and Goldberg, 2011) .
It has been proposed that cellular growth mechanisms present in replicating cells outside the nervous system are conserved in postmitotic neurons and may play key roles in axon growth (Park et al., 2008) . Tumor-suppressive factors that prevent aberrant proliferation in dividing cells may act to restrict axon growth in neurons, whereas factors with oncogenic properties may act to promote axon growth (Pomerantz and Blau, 2013) . Supporting this concept, signaling pathways involved in cancer progression have been found to affect neurite outgrowth (Buchser et al., 2010) , most notably the mTOR pathway (Park et al., 2008) and the oncogene MYC (Belin et al., 2015) . Furthermore, TFs such as KLF family members and Sox11, shown recently to promote CNS axon regeneration, are also well-has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier. 4 studied in cancer biology (Blackmore et al., 2012 and Wang et al., 2015) . These findings suggest that additional transcription factors, identified previously as displaying oncogenic or tumor suppressive properties in mitotically active cells, may regulate axon extension in neurons.
To test this hypothesis we adopted a high content screening strategy in which 69 TFs, implicated previously in cancer progression, were overexpressed in assays of neurite outgrowth. Nine of these TFs were found to significantly alter neurite length, of which a tumor suppressor called Hematopoietically Expressed Homeobox (HHEX) was among the most consistent and potent growth inhibitors. In follow-up experiments we confirmed strong suppression of axon growth by HHEX without a corresponding decrease in cell viability. Moreover, although HHEX has previously been described only in non-neuronal tissues, we show expression of HHEX in the CNS that is widespread and specific to neurons. In contrast we detected only low levels of HHEX in early postnatal CNS and adult PNS neurons, and found that forced elevation of HHEX expression reduces axon growth ability. Overall these data substantiate the mechanistic link between axon growth and general cellular growth at the level of transcriptional control, and suggest that the tumor suppressor HHEX may function as a novel transcriptional inhibitor of axon growth in the CNS.
Methods

Cloning and plasmid preparation
For screening and cell viability experiments, DNA was prepared (QIAprep Spin Miniprep Kit, Qiagen 27106) from glycerol stocks of NIH Mammalian Genome Collection in pSPORT6-CMV expression vectors (Open Biosystems, ThermoFisher, Huntsville, Alabama) (Gerhard et al., 2004) . To create constructs for domain mutation analysis, a CAMKIIa promoter sequence ((Zhang et al., 2007) , Addgene #20944)) replaced the original CMV in pAAV-EBFP-2A-mCherry backbone (described previously, (Blackmore et al., 2012) ), generating pAAVCAMKIIa-EBFP-2A-mCherry. Next, a Histone-2B sequence ((KitaMatsuo et al., 2009 ) (Addgene #21217)) was inserted 5′ to mCherry. cDNA encoding human HHEX (Accession BC050638) was purchased accessed by following the link in the citation at the bottom of the page. Neuroscience, Vol 68 (September 2015) : pg. 272-283. DOI. This article is © Elsevier and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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from Open Biosystems. The open reading frame (aa 1-270) was PCRamplified and used to replace EBFP, creating CAMKIIa-HHEX-2A-H2B-mCherry. To create additional constructs, full length HHEX was replaced with amino acids 137-270 (Homeodomain and Activation domain, HHEX-ΔN), HHEX-ΔN fused to an Engrailed domain, as described in Blackmore et al. (2012) , or amino acids 1-210 (repression domain and homeodomain, HHEX-ΔC). DNA was prepared by EndoFree Plasmid Maxi Kit (Qiagen 12362) and diluted to 1 μg/μl in endotoxin-free TE buffer.
Cortical cell dissociation, transfection, and culture
All animal procedures were approved by the Marquette University Institutional Animal Care and Use Committee. Cortical neurons were prepared from Sprague Dawley rat pups (Harlan) and transfected as in Blackmore et al. (2010) . Briefly, early postnatal (P3-P5) frontal cortices were placed in ice-cold Hibernate E (Life Technologies A12476-01), their meninges removed, minced finely and transferred into 10 ml dissociation media for 30 min at 37 °C with constant shaking (HibernateE containing 20 U/ml papain (Worthington 3126) and 2.5 μg/ml DNAse (Sigma D4527)). Cells were then rinsed with Hibernate E + 2% SM1, gently triturated three times, rinsed in Hibernate E (no SM1), and incubated 30 min at 37 °C with constant shaking in 10 ml trypsin solution (Hibernate E containing 0.25% trypsin (Invitrogen/Gibco 15,090-046) and 2.5 μg/ml DNAse (Sigma D4527)). Cells were pelleted, washed with Hibernate E + 2% SM1, and triturated three times in 1.5 ml Hibernate E + 2% SM1 containing 2 μl DNAse (Sigma D4527). The suspension settled for 2 min and the supernatant was collected; the process was repeated until no cell clumps were visible. Collected cells were washed and resuspended in 6-7 ml Hibernate E, typically yielding 2 million cells/ml. For transfection, cortical neurons were pelleted and resuspended to 2 × 10 6 cells/ml in Internal Neuronal Buffer (INB) (KCl 135 mM, CaCl2 0.2 mM, MgCl2 2 mM, HEPES 10 mM, EGTA 5 mM, pH 7.3). 25 μl were placed into wells of a 96-well electroporation plate (BTX Harvard Apparatus 45-0450) and mixed with 25 μl of INB containing 1 μg EGFP plasmid and 4 μg test plasmid. A 350 V, 300 μs pulse was delivered to each well by an ECM square wave pulse generator (Harvard Apparatus ECM-830) attached to a plate handler (BTX Harvard Apparatus HT-has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier. 6 200). 100 μl of Hibernate E was added to each well following electroporation. For cell culture, 10,000 cells/well were placed in 24-well plates (Greiner Bio-One 662,160) pre-coated with 100 μg/ml polyd-lysine hydrobromide (Sigma P7886) (> 12 h, 37 °C), followed by 10 μg/ml laminin (Sigma L2020) (> 2 h, 37 °C). For inhibitory substrates, 25 μg/ml Chondroitin Sulfate Proteoglycans (Millipore CC117) were added to 10 μg/ml laminin and incubated concurrently with laminin alone treatments. Cells were maintained at 37 °C, 5% CO2 in Enriched Neurobasal (ENB) media, modified from (MeyerFranke et al., 1995) , consisting of Neurobasal A (Invitrogen 10,888-022), 50X NeuronCult SM1 Neuronal Supplement (Stemcell Technologies 5711), 1 mM sodium pyruvate (Invitrogen 11360-070), 2 mM GlutaMAX (Invitrogen/Gibco 35050-061), 50 U/ml PenicillinStreptomycin (Invitrogen 15070-063), 5 μM Forskolin (Sigma F6886).
Sensory cell dissociation, transfection, and culture
Dorsal root ganglia neurons (DRGs) were isolated from freshly euthanized mice and digested with a solution of collagenase (0.5 mg/ml, Invitrogen 17105-041) and dispase (10 mg/ml, Invitrogen 17100) at 37° for 40 min. Cells were brought to single suspension with pipette trituration and then pelleted at 80 G for 5 min. The cell pellet was resuspended in the P3 Primary Cell Nucleofector kit solution (Lonza CC-4461) and approximately 20,000 DRG neurons were transfected with 1 μg of EBFP-2A-H2B-mCherry or HHEX-2A-H2B-mCherry plasmid DNA using the CA-138 program on the 4D-Nucleofector™ System (Lonza). After transfection 80 ul of warm PNGM™ Primary Neuron Growth Medium (Lonza CC-4461) was added to each electroporation well. The entire resulting cell solution was placed into a single well of a 24-well tissue culture plate (Corning). After 72 h, cells were trypsinized, pelleted at 900 G for 3 min, and then resuspended in 200 ul of warm media. The cell suspension was divided between two wells in a 24-well tissue culture dish. 15 h after replating, the cells were fixed and immunostained with a neuronal specific tubulin rabbit polyclonal antibody (1:2000, Sigma T2200) followed by secondary application of Alexa Fluor® 555 dye (Life Technologies A-21430) and Hoechst dye (0.5 μg/ml, Sigma B2261) to enable nuclei detection. has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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Cortical cell culture immunohistochemistry
Cultures were fixed in 4% paraformaldehyde (Electron Microscopy Sciences 15710) for 30 min at room temperature, rinsed five times, blocked and permeabilized (PBS, 20% goat serum (Invitrogen 16210-064), 0.2% Triton X-100 (G-Biosciences 786-513) for 30 min at room temperature, and incubated in primary antibody solution (PBS, 10% goat serum, 0.2% Triton X-100, primary antibodies: rabbit anti-βIII-tubulin (1:500, Sigma T2200), mouse antiTau-1 (1:1000, Millipore MAB3420), rabbit anti-MAP2 (1:2000, Millipore AB5622), mouse anti-HHEX (1:200, Sigma SAB1403914)) (overnight, 4 °C). After five washes, cultures were incubated in secondary antibody solution containing DAPI nuclear stain (PBS, 10% goat serum, 0.2% Triton X-100, 300 nM DAPI, dilactate (molecular probes D3571) Secondary antibodies: Alexa Flour 647 goat anti-rabbit IgG (1:500, Invitrogen A21245), Alexa Fluor 488 goat anti-mouse IgG (1:500, Invitrogen A11001)) for 2 h at room temperature. Plates were washed five times, and left in 1 ml PBS for imaging.
Cortical and DRG tissue staining
Adult brains were snap frozen, cryosectioned into 20 μm sections, post-fixed in 4% PFA (20 min, room temperature), blocked (1 h, room temperature), and incubated in primary antibody solution (primary antibodies: anti-HHEX (1:100, Sigma SAB1403914, LSBio LSB3077), anti-NeuN (1:100, MAB377A5)) overnight at 4 °C. After five washes with PBS, sections were incubated in secondary antibody solution (2 h, room temperature), and stained with 300 nM DAPI (20 min, room temperature). Slides were washed with PBS three times and mounted with Fluoro-gel (Electron Microscopy sciences 1798510). CST retrograde labeling was performed on injured animals as in (Wang et al., 2015) . Briefly, a 0.85 mm deep lesion was made 1 mm to the left of the midline between C4/C5. 1 μl CTB-Alexafluor 647 (Life Technologies C-34,778) was injected at C4/C5 seven days prior to sacrifice and snap freezing. has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier. 8
Imaging and quantification of neurite length
For neurite outgrowth assays, Cellomics Cell Insight NXT (Thermo Scientific) acquired images of 3 channels: nuclei (DAPI), neurite staining (βIII-tubulin), and reporter (EGFP), and Cellomics Scan v6.4.0 (Thermo Scientific) traced neurites and quantified reporter intensity. Average total neurite length was quantified for the 10% of cells with greatest EGFP intensity per plate (n > 100 cells per treatment). Average neurite length was normalized to mCherry control for each plate. Each treatment was tested at least three times; those that differed significantly from mCherry control were flagged as hit genes (*p < .05 ANOVA with post-hoc Dunnett's). For axon growth and differentiation assays, a fluorescent inverted microscope was used to identify mCherry + MAP2 + cells as transfected neurons. Axons were identified by Tau-1 staining, and hand traced using NIS-Elements Basic Research software. Axon length for neurons with an axon and percentage of neurons with an axon were quantified for n = 75 cells per treatment. Statistical analysis was paired t-test using Graphpad Prism Software.
For DRG neurite outgrowth assays, a Cellomics ArrayScanXTI (Thermo Scientific) acquired images in 3 channels: nuclei (Hoechst), neurite staining (βIII-tubulin), and reporter (mCherry), and the Neuronal Profiling v4.1 algorithm (Thermo Scientific) traced neurites and quantified reporter intensity. Cells were considered mCherry + when the pixel intensity in the cell reached 2 standard deviations above the mean intensity for mCherry in non-transfected control wells. Average neurite length was normalized to EBFP-2A-H2B-mCherry for each plate. The experiment was repeated three times. Statistical analysis was paired t-test using Graphpad Prism Software.
Cell survival assay
Cortical neurons were transfected and cultured as previously described, using HHEX as the test gene and an EBFP-2A-mCherry reporter in place of EGFP. After one day in culture, 1 μM staurosporine toxin (Sigma S5921) was added to a subset of EBFP-2A-mCherry wells. The following day media was replaced with either 0.05 μM Calcein AM (Life Technologies C3099), or 0.01 μM Yo-Pro-1-Iodide has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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(Life Technologies Y3603), both in PBS and containing 1 μg/ml Hoechst 33342 (Molecular Probes H1399), and incubated (30 min, 37 °C). Cellomics Cell Insight NXT (Thermo Scientific) acquired images for three channels: nuclear (Hoechst 33,342), cell survival stain (Calcein AM or Yo-Pro), and reporter (EBFP-2A-mCherry); compartmental analysis quantified intensities for each channel, and data were exported to Excel for analysis. The percentage of surviving cells (Hoechst +/Calcein AM +) and the percentage of apoptotic cells (Hoechst +/Yo-Pro-1-Iodide +) were quantified in five independent experiments. Statistical analysis was by ANOVA with post-hoc Dunnett's was performed using Graphpad Prism Software.
Western blotting
Lysates for Western blotting were prepared from HEK293 cells that were transfected with either EBFP-2A-H2B-mCherry or HHEX-2A-H2B-mCherry plasmids according to manufacturer's instructions (Lipofectamine 2000, Invitrogen 11668-027). Two days post incubation, cells were lysed using 200 μl lysis buffer (150 Mm sodium chloride, 1.0% Triton-X 100, 0.5% sodium deoxycholate, 0.1% SDS, 50 Mm Tris with protease inhibitors according to manufacturer's instructions (Roche 5892791001)), and cell debris was removed through centrifugation at 4° for 15 min at 21,000 rcf. P3 cortex, adult cortex and adult DRGs tissues were collected into 200-500 μl lysis buffer, and lysed using a homogenizer (VWR KT885450-0020), incubated on ice for 30 min and cell debris was removed through centrifugation at 4°. Protein concentration was estimated using the BCA method. A portion of the lysate (10-40 μg of protein) was fractionated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and the separated proteins were transferred to a PVDF membrane. Specific antibodies (Sigma SAB1403914; LSBio LSB3077; 1:1000 dilution) were used to probe for HHEX protein. Immune complexes were detected with suitable secondary antibodies and chemiluminescence reagents (ThermoScientific). β-actin primary antibody (ab6276, 1:2500 dilution) was used to ensure equal gel loading and transfer. has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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Results
High content screening of cancer related transcription factors
We first used existing datasets to examine the potential overlap between TFs implicated in cancer biology with TFs linked to axon growth. Using the Gene Ranker tool maintained by the Memorial Sloan Kettering Cancer Center, we acquired a list of 1258 genes that are strongly correlated with and/or functionally linked to oncogenesis or tumor suppression. This list contained 254 TFs, as defined by Gene Ontology terms DNA Binding and Regulation of Transcription, DNA Template. Of these, 166 TFs are expressed in the adult and/or developing cortex according to the Allen Brain Atlas (Supplementary Table 1 ). Intriguingly, these 166 cancer-related TFs included many genes that are already known to regulate axon growth, including 9 out of 10 factors discussed in a recent review of the transcriptional control of axon growth (ATF3, CREB, JUN, KLF4 and -6, NFKB1, SNON, the SOXC family, STAT3, and p53/TP53) (Gao et al., 2004 , Qiu et al., 2005 , Stegmuller et al., 2006 , Gallagher et al., 2007 , Seijffers et al., 2007 , Jankowski et al., 2009 , Moore et al., 2009 , Tedeschi et al., 2009 , Lerch et al., 2014 and Wang et al., 2015 .This high degree of overlap supports the notion of common transcriptional mechanisms that influence growth across diverse cell types, and raised the question of whether other cancer-implicated TFs on the list, many of which are unstudied in a neuronal context, might also act as regulators of axon growth.
We therefore used an established high content screening approach to quantify how cancer-related TFs affected neurite outgrowth when expressed in cortical neurons (Moore et al., 2009 , Blackmore et al., 2010 and Lerch et al., 2014 . Sixty-nine cancerrelated TFs were examined. Importantly, this subset was an effectively random sample based on availability in pre-made expression libraries (Open Biosystems), and not selected by user prioritization. Postnatal rat cortical neurons were co-transfected with plasmid DNA encoding test genes and a fluorescent reporter plasmid and then cultured on laminin substrate. Two days later, automated microscopy (ThermoScientific CellInsight Nxt) quantified neurite outgrowth from has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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cells identified as neurons through βIII tubulin immunostaining (Fig.  1B) and positive for transfection through expression of EGFP reporter (Fig. 1C ). Each gene was tested in three independent experiments, and neurite lengths were normalized to mCherry control (Supplementary Table 1 ). The set of "cancer" genes included JUN, a known promoter of neurite growth, as well as KLF4 and KLF6, shown previously to inhibit and promote neurite growth, respectively (Moore et al., 2009 , Blackmore et al., 2010 and Lerch et al., 2014 . These genes therefore functioned as positive controls. As expected, KLF4 significantly reduced (73.3% ± 3.7%, p < 0.01) and KLF6 and JUN expression significantly increased (125.8% ± 5.6%, 126.2% ± 6.9%, p < 0.01) neurite lengths, confirming the screen's ability to detect TFevoked changes in neurite length. Notably, in addition to the controls, 6 candidate genes significantly altered neurite lengths, with 2 acting as growth enhancers and 4 as suppressors (Fig. 1E ). In summary, nearly 15% of candidate TFs, selected on the basis of their involvement in cellular growth outside the nervous system, displayed an ability to modulate neurite outgrowth in primary neurons. Fig. 1 . Phenotypic screening of oncogenic and tumor suppressive transcription factors identifies HHEX as an inhibitor of neurite outgrowth. P3 cortical neurons were cotransfected with EGFP and either mCherry control or test plasmid and cultured on laminin substrates for two days. (A-D) Images were acquired through automated microscopy (nuclear: DAPI, neuronal: βIII-tubulin, transfection: EGFP). Cells positive has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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for neuron-specific βIII-tubulin and EGFP (arrowheads, B and C) were used for subsequent analyses. (E) Bars show the average neurite length in cells expressing 69 test genes across three replicate experiments (dots), normalized to mCherry control. Test genes included KLF4, KLF6, and JUN, all of which showed expected changes in neurite length, confirming assay sensitivity. Six additional test genes significantly altered neurite length, two positively and four negatively. HHEX (black bar) strongly and consistently inhibits neurite outgrowth. *p < .05 ANOVA with post-hoc Dunnett's, N > 100 cells in three replicate experiments. Scale bar is 50 μm.
HHEX inhibits axonogenesis without affecting viability
The homeodomain factor HHEX emerged from the initial screening experiment as one of the most potent and consistent inhibitors of neurite outgrowth, and was prioritized for additional analysis. To better characterize the effects of HHEX on neuronal morphology we performed a time-course experiment with axonspecific Tau1 antibodies (Fig. 2) . Postnatal cortical neurons were transfected with either HHEX plasmid DNA or EBFP control, and axon formation and length were quantified by hand tracing of Tau1-positive neurites. About 35% of control-transfected neurons extended an axon (Tau1 + process) within 24 h of plating, and the percent of axonbearing neurons increased steadily to a plateau of about 90% by three days in vitro (DIV; Fig. 2C ). In contrast, within 24 h of plating only 21% of HHEX-transfected neurons extended a Tau + axon (Fig. 2C) , and the percent of axon-bearing HHEX-transfected neurons never rose above 45%. These data confirm that HHEX expression interferes with axonogenesis. To determine whether HHEX also affects the rate of extension of existing axons we hand-traced Tau1 + processes at 2 and 3DIV; quantification at 4DIV was prevented by overgrowth of axons that prevented clear discrimination of the cell of origin. At 2DIV, axon length in HHEX-expressing neurons was 44% lower than control (161 μm ± 26.7 μm SEM versus 284.4 μm ± 36.8 μm SEM; p < 0.01, paired T-test) (Fig. 2D) . Over the next 24 h, control neurons increased average axon lengths to 653.3 μm ± 76.4 μm SEM (an average net addition of 368.9 μm), while HHEX-expressing neurons increased to 357.5 μm ± 40.0 μm SEM, (an average net addition of 195.5 μm). These data indicate that HHEX expression does not simply delay axon formation, but also slow net axon growth between 2DIV and 3DIV. Consistent with this, a time-course analysis using automated tracing showed that HHEX and EBFP-transfected neurons displayed similar neurite lengths at the one day time-point, but that the subsequent daily increases in neurite length were more than 50% lower in HHEXexpressing neurons (Supplemental Fig. 1 ). Thus HHEX expression also appears to decrease the rate of elongation of extant processes.
We next considered the possibility that the effect of HHEX on axon growth could be secondary to a reduction in cell viability. This issue is particularly important given the involvement of HHEX in cell proliferation in non-neuronal cells, and findings that modulation of cell cycle regulators can induce apoptosis in post-mitotic neurons (Kranenburg et al., 1996 and Nguyen et al., 2002; Greene et al., 2004 and Hoglinger et al., 2007) . Cortical neurons were transfected with HHEX or EBFP control plasmid carrying mCherry reporter, and a third group of EBFP-transfected neurons were treated with the toxin staurosporine as a positive control for reduced viability. After two days in culture, a time point at which effects on axon growth are robust (Fig. 2) , Cellomics image analysis quantified the percent of transfected (mCherry +) neurons that stained positively for Yo-Pro-1-Iodide or has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
14 Calcein AM, indicators of apoptotic and live cells respectively (Fig. 3A-F) . As expected, staurosporine elevated Yo-Pro and decreased Calcein signal, confirming the sensitivity of the assay. In contrast, HHEXtransfected neurons showed neither elevated Yo-Pro signal nor decreased Calcein compared to EBFP control (Fig. 3G) . Combined, these experiments confirm that HHEX overexpression interferes with axonogenesis and slows axon elongation, without any corresponding decrease in cell viability. 
Mutation analysis suggests transcriptional repression as relevant mechanism
Wild type HHEX protein is comprised of a DNA binding domain flanked by an N-terminal domain that mediates transcriptional repression (Tanaka et al., 1999) , and a C-terminal domain that mediates transcriptional activation (Kasamatsu et al., 2004 and Soufi and Jayaraman, 2008) . Thus, depending on cellular context, HHEX can either activate or repress target genes, raising the question of which has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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activity is relevant to the suppression of axon growth. We therefore created HHEX truncation mutants that lacked either the activation domain (HHEX-∆C) or the repression domain (HHEX-∆N), and tested their effects on neurite outgrowth in cortical neurons, as described above (Fig. 4) . All constructs included a 2A-H2B-mCherry fluorescent reporter, allowing specific identification of transfected cells. In addition, the fluorescent reporter, as well as direct immunohistochemistry for HHEX protein, confirmed effective expression of all constructs. Removal of the repression domain, but not the activation domain, completely abolished growth inhibition, suggesting that transcriptional repression may be necessary for HHEX's effects on neurite growth (Fig. 4B) . Moreover, a chimeric construct in which the endogenous HHEX N-terminal domain was replaced by an alternative Engrailed repression domain phenocopied the full length HHEX repression of neurite outgrowth. This result indicates that transcriptional repression per se, as opposed to a nontranscriptional activity localized to the N-terminal HHEX sequence, causes inhibition of axon growth. Combined, these data identify transcriptional repression domains as both necessary and sufficient for HHEX's inhibition of neurite growth, and suggest a model in which HHEX normally inhibits gene targets that are needed for efficient neurite extension. Fig. 4 . A transcriptional repression domain is both necessary and sufficient for HHEX's inhibition of neurite growth. Domain-deletion and domain-swapped HHEX mutants, shown schematically in (A), or EBFP control plasmids were overexpressed in early has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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postnatal cortical neurons and cultured for two days. (B) Neurite outgrowth was quantified by automated microscopy. HHEX-ΔC inhibits neurite growth similarly to full length HHEX, showing that the C-terminal activation domain is dispensable for growth inhibition. In contrast, removal of the N-terminal domain abolished growth inhibition. Finally, Engrailed-HHEX also inhibits neurite growth. These experiments suggest that HHEX likely inhibits neurite outgrowth through a mechanism of transcriptional repression. **p < .01, ANOVA with post-hoc Dunnett's. N > 150 transfected cells in each of five replicate experiments.
HHEX is expressed in adult CNS neurons
Although CNS expression is suggested by in situ data from the Allen Brain Atlas, HHEX has been previously described only in hematopoietic lineages and in endoderm-derived tissues such as thyroid, pancreas, liver, and lung (Bogue et al., 2000 and Soufi and Jayaraman, 2008) . To establish HHEX's relevance to axon growth it is therefore essential to examine its endogenous pattern of expression in the nervous system. We first validated two anti-HHEX antibodies using HHEX-transfected HEK293 cells. As expected, control-transfected 293 cells displayed no HHEX expression by immunohistochemistry or Western blotting, whereas HHEX-transfected cells showed clear signal with both antibodies (Supplemental Fig. 2 ). These data demonstrate the specificity of the anti-HHEX antibodies in both immunohistochemistry and Western blotting experiments.
We first examined HHEX expression in the adult murine cortex by Western blot, and observed a clear ~ 42 kD band at the same position as overexpressed full-length HHEX (Fig. 5A) . These data confirm expression of HHEX protein in the adult cortex. In contrast, cortex from postnatal day 3 (P3), the age at which cells were prepared for neurite outgrowth assays, did not show detectable expression of HHEX by Western blotting. Consistent with this, immunohistochemistry on cultured P3 cortical neurons detected no endogenous HHEX in cells transfected with EBFP control plasmid, but did confirm the presence of HHEX protein in cells transfected with HHEX plasmid (Fig. 5B-E) .
Combined, these data demonstrate expression of HHEX in cortical tissue of adult but not early postnatal age. has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier. To further explore the relationship between HHEX protein expression and neurite length we visualized HHEX protein in HHEXtransfected or EBFP-transfected control neurons while simultaneously measuring neurite lengths. Quantification of the intensity of HHEX immunohistochemistry signal in HHEX-transfected neurons showed a range of intensities above the background level in control cells, indicating variable levels of HHEX protein expression (Supplemental Fig. 3) . Analysis of average neurite lengths, binned according to increasing levels of HHEX protein, confirmed a significant reduction in neurite length in neurons with elevated HHEX expression. Neurite has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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lengths were significantly reduced in neurons with relatively modest HHEX expression, such that neurons within the second quintile of HHEX intensity were 71.2% of control length (p < .05, ANOVA with Dunnet's post-hoc), with neurons in the brightest HHEX quintile averaging 56.1% of control. These data confirm with direct detection that increased expression of HHEX protein in postnatal cortical neurons reduces neurite outgrowth.
To determine whether HHEX is expressed specifically in neurons in the adult brain, as opposed to other cell types, we examined murine brain sections by immunohistochemistry, using NeuN as a neuronal marker. Intriguingly, we observed a striking and complete overlap between HHEX and NeuN reactivity (Fig. 5F-K) . HHEX was detected in all NeuN + nuclei examined in the forebrain, midbrain and hindbrain and was not detected in adjacent NeuN-negative nuclei, indicating expression that is widespread and highly specific to neurons. To confirm these findings we repeated the experiment with a second antibody against HHEX that was raised against a distinct epitope, with identical results (Supplemental Fig. 4) . To assess HHEX expression in CNS neurons that are responding to axotomy, we performed spinal transections and injected retrograde tracers to the injury site to identify axotomized corticospinal tract (CST) neurons. Two weeks post-injury, HHEX was readily detectable in all injured CST neurons, and the intensity of staining appeared neither elevated nor decreased (Fig. 6) . These data show expression of HHEX protein in the adult CNS neurons, including CST neurons after spinal injury. has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier. Axon growth in the adult CNS is constrained in part by inhibitory substrates such as chondroitin sulfate proteoglycans (CSPGs) (Carulli et al., 2005) . We therefore explored potential interactions between CSPG substrates and HHEX expression by culturing neurons on substrates of laminin (10 μg/ml) or a mixture of laminin and CSPGs (10 μg/ml laminin, 25 μg/ml CSPGs) and performing immunohistochemistry for HHEX. HHEX was detectable on neither substrate, and automated microscopy confirmed similar levels of HHEX signal on laminin and CSPG substrates. As a positive control the immunohistochemistry, HHEX was readily detectable in HHEXtransfected cells. (Fig. 7A-E) . These data indicate that HHEX expression is insensitive to CSPG exposure. has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier. (F) Neurite lengths were significantly reduced on CSPG substrates. On both laminin and CSPG substrates, transfection with HHEX plasmids decreased neurite lengths compared to EBFP control. **p < .01, two way ANOVA, N > 100. Scale bar is 10 μm.
Next, to test whether HHEX-mediated inhibition of neurite outgrowth was affected by CSPG substrates, neurons were transfected with HHEX or control plasmid and cultured on laminin or CSPG substrates. As expected, neurite outgrowth by control-transfected neurons was reduced on CSPG substrates (69.9% shorter than on laminin) (Fig. 7F) . On laminin substrate, HHEX expression caused a 39% reduction in neurite length compared to mCherry control. On CSPG substrates, HHEX also reduced neurite lengths, and did so to a degree that was proportional to the effect on laminin (35% shorter than control-transfected neurons on CSPGs). Combined with the insensitivity of HHEX expression to CSPG, these data suggest that the has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier. 21 molecular mechanisms that mediate growth inhibition by HHEX function independently of those triggered by CSPG substrates.
HHEX expression and function in peripheral neurons
We next examined HHEX expression in peripheral neurons of the dorsal root ganglia (DRG), which possess a generally higher regenerative capacity than CNS neurons. Immunohistochemistry for HHEX showed very dim signal in sections of adult DRG; as a positive control, adult cortical tissue processed in parallel and visualized with identical acquisition parameters showed bright HHEX signal (Fig. 8A,  B) . Similarly, Western blotting in DRG tissue detected very faint sizeshifted bands, but no HHEX protein in a position corresponding to overexpressed HHEX protein or to protein detected in adult cortex (Fig.  8C ). Adult DRG neurons are known to extend lengthy processes when placed in culture, and this response requires extensive transcriptional changes that occur in the days after plating. We therefore performed immunohistochemistry for HHEX in DRG neurons that were transfected with EBFP-2A-H2B-mCherry control or HHEX-2A-H2B-mCherry and maintained in culture for three days (Fig. 8D-G) . HHEX protein was not detected in control-transfected DRG neurons, but was readily detectable in HHEX-transfected cells (Fig. 8D-G) . Combined, these data suggest that unlike CNS neurons, regeneration-competent PNS neurons do not express detectable amounts of HHEX protein in neither the uninjured state, nor when engaged in injury-triggered axon growth. has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier. We therefore tested the effects of elevating full-length HHEX expression in DRG neurons. Cultured DRG neurons were transfected with plasmids encoding HHEX or EBFP, maintained for the three days, and then replated to remove existing neurites. The amount of neurite growth generated in the subsequent 24 h was then quantified. This paradigm avoids technical problems associated with excessive axon growth by DRG neurons during the lag between plasmid transfection and protein function. Immunohistochemistry confirmed exogenous HHEX expression (Fig. 8F, G) . Compared to EBFP control, HHEX expression significantly reduced the number of neurites by 2-fold and the total length of neurites produced by DRG neurons (Fig. 9) .
Combined, these data demonstrate that ectopic expression of full-has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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length HHEX, normally absent in PNS neurons, is sufficient to reduce the regenerative capacity of DRG neurons. 
Discussion
This study used a screening approach to identify the homeodomain factor HHEX, previously studied as a tumor suppressor in hematopoietic and endodermal lineages, as a potent suppressor of axon growth when overexpressed in CNS neurons. Our data suggest that HHEX may act through a mechanism of transcriptional repression to reduce both axon initiation and extension, without negatively affecting cell viability. Moreover, HHEX is endogenously expressed in Molecular and Cellular Neuroscience, Vol 68 (September 2015) : pg. 272-283. DOI. This article is © Elsevier and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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the nuclei of CNS neurons, including CST neurons after axotomy. In contrast, peripheral DRG neurons express much lower levels of HHEX, and forced expression of HHEX reduces DRG axon growth. Combined, the phenotypic effects and pattern of expression support the hypothesis that transcriptional repression by HHEX may limit axon growth in CNS neurons.
Transcriptional inhibition of axon growth
In contrast to HHEX, the majority of TFs that have previously been linked to axon growth appear to play pro-regenerative roles, likely by coordinating the production of multiple growth-associated proteins. Prominent examples include JUN, ATF3, KLF7, SOX11, STAT3, and CREB, all of which are active in neurons that mount successful axon regeneration but are missing or inactive in nonregenerating cell types (Gao et al., 2004 and Qiu et al., 2005; Seijffers et al., 2007 , Jankowski et al., 2009 , Blackmore et al., 2012 and Lerch et al., 2014 . Accordingly, we and the others have pursued forced expression of these TFs as a strategy to enhance axon growth (Qiu et al., 2005 , Seijffers et al., 2007 , Jankowski et al., 2009 , Blackmore et al., 2012 , Lerch et al., 2014 and Wang et al., 2015 . It is well appreciated, however, that regenerative ability can also be held in check by the presence of cell-intrinsic factors that limit growth potential. Thus, at the level of gene transcription, it may be necessary to complement the overexpression approach by neutralizing TFs that repress transcription by occupying pro-regenerative loci. The identity of such growth-inhibitory TFs, however, remains unclear. Members of the KLF family, notably KLF4, are likely candidates because they are expressed in poorly-regenerating CNS neurons and contribute to their low regenerative capacity (Moore et al., 2009 ). Whether KLF4 acts as a transcriptional repressor of pro-regenerative genes, as opposed to alternative mechanisms such as activation of growth inhibitory genes, has not been established.
In this context it is significant that the functional domain analyses suggest that HHEX inhibits axon growth through a mechanism of transcriptional repression. Although HHEX is known to be capable of either activating or repressing target genes, the domain deletion experiments showed that a known activation domain is has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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dispensable, and a known repression domain essential, for inhibition of neurite outgrowth. In addition, evidence that the Engrailed repression domain can effectively substitute for the endogenous HHEX repression domain makes it likely that transcriptional repression, and not an alternative function specific to the HHEX N-terminal sequence, drives inhibition of neurite growth. Direct assays of transcriptional activity (e.g. luciferase assays with promoter mutations/deletion) are needed to confirm HHEX's transcriptional mode of activity, but the experiments reported here support a working model in which HHEX transcriptionally represses gene products needed for efficient axon growth.
HHEX is relatively unstudied in the nervous system, but well characterized in other systems. HHEX functions as an essential regulator of vertebrate development, controlling hematopoietic and vascular system formation as well as formation of the vertebrate body axis early in development (Soufi and Jayaraman, 2008) . HHEX is also essential for the formation and maintenance of organs derived from the foregut endoderm such as thyroid, liver and lung (Bogue et al., 2000) . HHEX knockout animals die embryonically around day 12 and show anterior truncation including a lack of forebrain tissue, but this defect has been interpreted as secondary to defects in the anterior visceral endoderm signaling center (Martinez- .
In adult mammals, we find that full length HHEX is widely expressed in neurons throughout the central nervous system, with expression localized to neuronal nuclei. Consistent with a role for HHEX in axon growth inhibition, we observe that CST neurons, which are generally refractory to regenerative axon growth, display HHEX expression after spinal injury. In contrast, HHEX appears to be much less abundant in early postnatal cortical neurons and in DRG neurons, both constitutively and during injury-triggered axon growth. When full length HHEX is overexpressed in early postnatal cortical neurons or DRG neurons, both of which are innately regeneration competent, we observe defects in both axon formation and extension. Immunohistochemistry showed that significant reductions in neurite length occurred in neurons with relatively dim immunohistochemistry HHEX signal. Although comparison between immunohistochemistry experiments must be made cautiously, it is notable that the intensity has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
26
of HHEX signal that produced significant reductions in neurite length in cultured neurons appeared comparable to or dimmer than the intensity of endogenous HHEX in the adult brain. Combined, these data are consistent with the notion that endogenous HHEX expression in adult neurons may restrict axon growth.
The identity of HHEX target genes in neurons remains unclear. In various proliferative cell types, a number of genes have been shown to change in expression upon HHEX overexpression or knockdown, including ESM1, VEGF, SST, KIT, and cyclin dependent kinases and associated inhibitors (Noy et al., 2010 , Shields et al., 2014 , Zhang et al., 2014 and Jackson et al., 2015 . In the case of ESM1, VEGFR, and SST direct binding of HHEX to promoter sites has been demonstrated, whereas other gene targets may be direct or indirect (Cong et al., 2006 , Noy et al., 2010 and Zhang et al., 2014 . In either case, the link between these known targets and the suppression of axon growth is not obvious. Intriguingly, HHEX has also been shown to inhibit the activity of JUN, a well-studied transcriptional promoter of axon growth that we confirmed here to increase neurite length (Schaefer et al., 2001 , Raivich et al., 2004 and Lerch et al., 2014 . HHEX was also recently shown to negatively regulate the activity of MYC, a TF implicated in cellular growth and proliferation, and very recently linked to axon regeneration in the optic system (Belin et al., 2015 and Marfil et al., 2015) . Determining direct and indirect gene targets of HHEX in neurons, and clarifying the potential interactions of HHEX with JUN and/or MYC in the context of axon growth, represents important directions for future research.
Oncogenes and tumor suppressors as regulators of axon growth
The general notion that intracellular factors implicated in cancer biology could regulate axon growth has been previously proposed (Park et al., 2008) . Axon growth may depend on catabolic processes and cytoskeletal dynamics that contribute to cell proliferation and motility, much like what is observed in cancerous cells. Conversely, tumor suppressive molecules are in place to prevent aberrant growth upon maturation. Since many of these genes are expressed in postmitotic neurons, it raises a possibility that the tumor suppressor genes has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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may inhibit axonal growth and contribute to the reduced regenerative capacity observed in mature CNS neurons. In line with this, the protooncogene JUN drives regenerative axon growth (Raivich et al., 2004 and Lerch et al., 2014) whereas the tumor suppressor KLF4 restricts axon growth (Moore et al., 2009 ).
We therefore undertook a systematic evaluation of this idea by selecting factors based on their tumor suppressor/oncogenic properties and examining their effects on neurite growth. Approximately 13% about 2% (8/428) in a previous screen using similar techniques but which focused on genes that are developmentally regulated (Blackmore et al., 2010) . This relatively high hit rate corroborates the concept that mechanisms driving cellular growth and motility are conserved across cell types. Intriguingly, the two TFs that emerged as growth promoting in the screen (E2F1 and YAP1) are generally considered oncogenic (Alonso et al., 2008 and Liu et al., 2010a) , whereas the four growth-suppressors (HHEX, PITX1, RBM14, and ZBTB16) have been described as tumor suppressive (Kolfschoten et al., 2005 , Kang et al., 2008 , Soufi and Jayaraman, 2008 and Suliman et al., 2012 . Although it should be noted that factors cannot always be cleanly classified due to conflicting findings in different cell types (George et al., 2003) , the screen results support an overall correlation between oncogenesis and axon growth and tumor suppression with growth inhibition. Thus further study of factors implicated in cancer biology may be a productive means to identify new regulators of axon growth. has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.
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Supplemental Fig. 3 . Quantitative analysis of the relationship between neurite length and level of forced HHEX protein expression. Cortical neurons were transfected with EBFP control plasmid or HHEX and maintained in culture for three days on laminin substrates. Immunohistochemistry for βIII-tubulin and HHEX protein was performed and cells were analyzed by automated microscopy (Cellomics). (A) Each dot represents the average HHEX pixel values for an individual neuron. Values within three standard deviations of the mean of EBFP-transfected cells were defined as background. As expected, HHEX overexpression resulted in numerous cells with HHEX signal above background. (B) The intensity of detection of overexpressed HHEX was divided into quintiles, and the average neurite length of neurons falling within each quintile was calculated. Significant reductions in neurite length were apparent in quintiles 2 to 5. p < .01, ANOVA with post-hoc Dunnet's compared to EBFP-transfected neurons. More than 10,000 total cells were analyzed.
